Biotech Stock News (SRPT) (JUNO) (CELG) (AGTC) (VRTX)

Sarepta Therapeutics (NASDAQ:SRPT) On Monday June 29, 2015 Sarepta had announced that it had completed¬†its rolling submission of its New Drug Application — NDA — to the FDA. A rolling submission is an FDA policy whereby biotech companies can submit their marketing approval application in small parts on a rolling basis instead of doing it … Read more

Vertex Pharmaceuticals (VRTX) Stock Climbs | Regulatory Hurdle Cleared

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Vertex Pharmaceuticals stock is having an amazing day in the market today. After announcing that a regulatory hurdle has been cleared with regard to a cystic fibrosis drug developed by the company, investors seem to be incredibly excited. Today, we’ll talk about the regulatory hurdle that was cleared, what we’re … Read more